GRDX Q3 2024 Earnings Significant EPS Miss Amidst Operational Challenges Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline BETR Q1 2026 Earnings EPS Misses Consensus as Revenue Not Disclosed NRG Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher BYRN Q1 2026 Earnings EPS Misses Estimates Stock Advances on Strategic Progress EGP Q1 2026 Earnings EPS Beats Estimates by 681 Amid Flat Stock Movement